REUTERS NEWS SCHEDULE AT 10:00 a.m. GMT/ 6:00 a.m. ET
Here are the top stories and upcoming coverage plans for Reuters text service as of 10:00 a.m. GMT/ 6:00 a.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect or on Media Express.
TOP STORIES
GLOBAL
UKRAINE-CRISIS/ATTACK-RUSSIA
Ukraine strikes Moscow in biggest drone attack to date
Ukraine struck the Moscow region on Tuesday in its biggest drone attack so far on the Russian capital, killing at least one woman, wrecking dozens of homes and forcing around 50 flights to be diverted from airports around Moscow.
ISRAEL-PALESTINIANS/GAZA
Dozens killed, wounded in Israeli strikes on Gaza tent camp, Gaza agency says
CAIRO, Sept 10 (Reuters) - Israeli missiles set ablaze a tent camp for displaced Palestinians in southern Gaza, killing or wounding 65 people, the enclave's civil emergency service said on Tuesday, in what the Israeli military called a strike on a Hamas command centre.
U.S.
USA-ELECTION/DEBATE-PREVIEW
Philadelphia gears up for Harris-Trump debate with protests expected
PHILADELPHIA, Sept 9 (Reuters) - It is the birthplace of U.S. independence, the "City of Brotherly Love," and the hometown of beloved fictional boxer "Rocky" Balboa.
CHINA-US/MILITARY
Top US, Chinese military officials hold first video call
BEIJING, Sept 10 (Reuters) - The United States and China held theatre-level commander talks for the first time on Tuesday, Chinese authorities said, amid efforts to stabilise military ties and avoid misunderstandings, especially in regional hot spots such as the South China Sea.
BUSINESS
EU-TECH/REGULATION
Apple loses fight against $14.4 billion EU tax order to Ireland
BRUSSELS, Sept 10 (Reuters) - EU antitrust chief Margrethe Vestager scored two major wins on Tuesday as Europe's top court backed her crackdown against Apple's Irish tax deal and Google's anti-competitive practices in two landmark cases.
EU-ALPHABET/ANTITRUST
Google loses fight against $2.7 billion EU antitrust fine
BRUSSELS, Sept 10 (Reuters) - Alphabet's Google on Tuesday lost its fight against a 2.42 billion euro ($2.7 billion) fine levied by EU antitrust regulators seven years ago, one of a trio of hefty fines meted out to the company for various anti-competitive practices.
LIFESTYLE & ENTERTAINMENT
PEOPLE-JAMES EARL JONES/
James Earl Jones, renowned actor and voice of Darth Vader, dies at 93
LOS ANGELES, Sept 9 - American actor James Earl Jones, an imposing stage and screen presence who overcame a childhood stutter to develop a stentorian voice recognized the world over as intergalactic villain Darth Vader, died on Monday at the age of 93.
AUSTRALIA-SOCIALMEDIA/CHILDREN
Australia plans social media minimum age limit, angering youth digital advocates
SYDNEY, Sept 10 (Reuters) - Australia plans to set a minimum age limit for children to use social media citing concerns about mental and physical health, sparking a backlash from digital rights advocates who warn the measure could drive dangerous online activity underground.
SPORTS
SOCCER-NEWZEALAND/USA
Soccer-New Zealand look to shock a US team in 'transition'
New Zealand may be smarting from a 3-0 defeat to Mexico but the world's 94th ranked side believe they can bounce back quickly and beat the U.S. in a friendly on Wednesday to build momentum before their next World Cup qualifying window.
OLYMPICS-2032/AUSTRALIA-TALENT
Olympics-Australia launches talent search for 2032 Brisbane Games
SYDNEY, Sept 10 (Reuters) - Australia will launch its biggest ever talent search next month to unearth the athletes who will compete on home soil at the 2032 Brisbane Olympics and Paralympics, the Australian Institute of Sport said on Tuesday.
UPCOMING
BUSINESS / ECONOMICS
SAMSUNG ELEC-INDIA/STRIKE
Workers' strike at Samsung India plant continues for second day
Hundreds of workers at a Samsung Electronics plant in southern India are expected to continue their indefinite strike for a second day to demand higher wages, partly hitting production.
10 Sep
GOLDMAN SACHS-TECH/
Tech companies presenting at Goldman Sachs Tech conference
Technology, media and telecom companies present at the four-day Goldman Sachs Communacopia + Technology Conference
10 Sep
INDIA-AUTOS/
India Automobile Manufacturers' Body Annual Meet
Reuters will attend an annual convention hosted by SIAM, which represents India's automobile manufacturers.
10 Sep 01:00 ET / 05:00 GMT
WICKES-RESULTS/
Half Year 2024 Wickes Group PLC Earnings Release\
10 Sep 02:00 ET / 06:00 GMT
GAMESTOP-RESULTS/
GameStop To Report Second Qaurter Results
GameStop is expected to post a fall in quarterly revenue hurt by slowing sales at its core business of selling new and pre-owned videogames.
10 Sep 12:00 ET / 16:00 GMT
USA-OIL/EIA
POLL: US weekly oil and product inventories, weekly data issued by EIA, API
An extended version of the poll issued initially on Monday. The poll gives analyst forecasts on weekly crude and product inventories that are released by the U.S. Energy Information Administration (part of the U.S. Department of Energy) and the American Petroleum Institute.
10 Sep 14:00 ET / 18:00 GMT
DUREX-INDIA/STRATEGY (PIX)
Condom brand Durex bets on women, rural consumers in new India push
For years, the world's biggest condom maker Reckitt Benckiser designed products and marketing to lure Indian men to its Durex brand. Now, it is unleashing a new strategy to grow in the Indian market by focussing on women and rural consumers.
11 Sep
GOLDMAN SACHS-TECH/
Tech companies presenting at Goldman Sachs Tech conference
Technology, media and telecom companies present at the four-day Goldman Sachs Communacopia + Technology Conference
11 Sep
USA-NATGAS/EIA (POLL)
POLL-U.S. natural gas stocks
A Reuters survey of analysts' expectations ahead of a weekly issue of natural gas inventory data by the U.S. Energy Information Administration (EIA).
11 Sep
INTERCEPT-LIVER DISEASE/
FDA's staff advisers release briefing documents for
Intercept's liver disease drug Staff advisers to the U.S. Food and Drug Administration will release briefing documents on Wednesday, highlighting their analysis of data for Intercept Pharmaceuticals' drug to treat a rare liver disease.
11 Sep
DUNELM-RESULTS/
Full Year 2024 Dunelm Group PLC Earnings Release
Britain's Dunelm will report higher annual profit helped by an ease in freight-related costs and steady demand for its home furnishing. The group will guide investors on its expectations for its fiscal 2025 at a time when big ticket purchases remain subdued. Comments on price actions and demand will be key.
11 Sep 02:00 ET / 06:00 GMT
WH SMITH-OUTLOOK/
WH Smith Pre Close Trading Update British retailer WH Smith is likely to post higher annual profits helped by a travel boom with travelers purchasing across its product offerings including meals, books and souvenirs.
11 Sep 02:00 ET / 06:00 GMT
FINTECH-CRYPTO/ADOPTION
Chainalysis' 2024 global adoption report
Chainalysis' report on 2024 Global Adoption Index on embargo for 8 a.m. ET
11 Sep 04:00 ET / 08:00 GMT
MANCHESTER UNITED-RESULTS/
Manchester United plc Fourth Quarter Fiscal 2024 Earnings
Manchester United will report heavy annual losses after a poor finish last season. The focus will now be on the strategic direction of new CEO Omar Berrada, who joined the club in July as part of an overhaul by new co-owner Jim Ratcliffe.
11 Sep 07:00 ET / 11:00 GMT
DOLLARAMA-RESULTS/
Dollarama Q2 2025 Earnings
Canadian discount store operator Dollarama is expected to post a rise in second-quarter revenue on Wednesday, helped by steady demand for its affordable groceries and essentials.
11 Sep 07:00 ET / 11:00 GMT
GOLDMAN SACHS-TECH/
Tech companies presenting at Goldman Sachs Tech conference
Technology, media and telecom companies present at the four-day Goldman Sachs Communacopia + Technology Conference
12 Sep
BRITAIN-ECONOMY/POLL
Reuters poll: BoE monetary policy and UK economy
Reuters publishes a poll of economists on their latest outlook for the Bank of England's monetary policy and the UK economy.
12 Sep
FEVERTREE-RESULTS/
Half Year 2024 Fevertree Drinks PLC Earnings Release Fevertree Drinks is likely to report improved half-year profits on robust demand for its tonic and other cocktail mixers.
12 Sep 02:00 ET / 06:00 GMT
IG GRP HLDGS - OUTLOOK/
Q1 2025 IG Group Holdings trading statement release British online trading platform IG Group is due to provide its first update for the ear, with softer market conditions expected to continue.
12 Sep 02:00 ET / 06:00 GMT
UNITEDHEALTH-CYBER/RIVALS
Rivals to UnitedHealth's tech unit say new, post-hack customers are staying
Smaller rivals to UnitedHealth's tech unit Change Healthcare are signing longer-term contracts with hospitals and other customers who had temporarily switched from the company after February's cyberattack shut down the unit's services.
12 Sep 02:00 ET / 06:00 GMT
KROGER-RESULTS/
Kroger Co Q2 2024 Earnings
Kroger is expected to post a rise in second-quarter revenue on Thursday, helped by strong demand for its low-priced groceries as consumers look to save dollar amid sticky inflation.
12 Sep 08:00 ET / 12:00 GMT
ADOBE-RESULTS/
Adobe To Report Third Quarter Results
Adobe is expected to report rise in quarterly revenue helped by strong demand for its artificial intelligence integrated photography, illustration, and video software.
12 Sep 16:00 ET / 20:00 GMT
INTERCEPT-LIVER DISEASE/FDA
FDA panel to discuss full approval for Intercept's liver disease drug
A panel of independent advisors to the U.S. Food and Drug Administration will meet on Friday to discuss and give recommendations to the health regulator on whether to grant traditional approval to Intercept Pharmaceuticals' drug Ocaliva as a treatment for a rare and chronic liver disease.
13 Sep 05:00 ET / 09:00 GMT
POLITICS / INTERNATIONAL AFFAIRS
BRITAIN-COMMERCIAL PROPERTY/
Smaller UK commercial property firms ripe for deal making
Britain's commercial real estate may see increased dealmaking this year as smaller firms, thumped by high interest rates and declining property valuations, become prime targets for larger players, six top executives and industry experts said.
10 Sep
BRITAIN-COMMERCIAL PROPERTY/
Smaller UK commercial property firms ripe for deal making Britain's commercial real estate may see increased dealmaking this year as smaller firms, thumped by high interest rates and declining property valuations, become prime targets for larger players, six top executives and industry experts said.
11 Sep
BRITAIN-COMMERCIAL PROPERTY/
Smaller UK commercial property firms ripe for deal making Britain's commercial real estate may see increased dealmaking this year as smaller firms, thumped by high interest rates and declining property valuations, become prime targets for larger players, six top executives and industry experts said.
12 Sep
SCIENCE / TECHNOLOGY
ROCHE-MULTIPLE SCLEROSIS/
US FDA decision on Roche's multiple sclerosis therapy
The U.S. Food and Drug Administration is expected to decide on approval of Roche and partner Halozyme Therapeutics under the skin formulation of ocrelizumab, a therapy to treat multiple sclerosis.
13 Sep
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
